Evidence map›Paper›PMID 37509614›Full record

ArticleBiomedicines2023

Calcium Channel Blockers and the Risk of Exacerbation in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Study of 48,488 Outpatients.

Ema Rastoder, Pradeesh Sivapalan, Josefin Eklöf, Imane Achir Alispahic, Alexander Svorre Jordan, Christian B Laursen, Jørgen Vestbo, Christine Jenkins, Rune Nielsen, Per Bakke and 7 more

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 5 countries.

Ema RastoderSection of Respiratory Medicine, Herlev-Gentofte Hospital, 2900 Hellerup, Denmark.
Pradeesh SivapalanSection of Respiratory Medicine, Herlev-Gentofte Hospital, 2900 Hellerup, Denmark.
Josefin EklöfSection of Respiratory Medicine, Herlev-Gentofte Hospital, 2900 Hellerup, Denmark.
Imane Achir AlispahicSection of Respiratory Medicine, Herlev-Gentofte Hospital, 2900 Hellerup, Denmark.
Alexander Svorre JordanSection of Respiratory Medicine, Herlev-Gentofte Hospital, 2900 Hellerup, Denmark.ORCID 0000-0002-5684-9375
Christian B LaursenDepartment of Respiratory Medicine, Odense University Hospital, 5000 Odense, Denmark.
Jørgen VestboAllergi-Og Lungeklinikken Vanløse, 2720 Copenhagen, Denmark.ORCID 0000-0001-6355-6362
Christine JenkinsDepartment of Thoracic Medicine, Concord Hospital, University of Sydney, Concord, NSW 2139, Australia.
Rune NielsenDepartment of Clinical Science, University of Bergen, 5021 Bergen, Norway.
Per BakkeDepartment of Thoracic Medicine, Haukeland University Hospital, 5021 Bergen, Norway.
Gustavo Fernandez-RomeroDepartment of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, PA 19122, USA.
Daniel ModinSection of Cardiovascular Medicine, Herlev-Gentofte Hospital, 2900 Hellerup, Denmark.
Niklas JohansenSection of Cardiovascular Medicine, Herlev-Gentofte Hospital, 2900 Hellerup, Denmark.ORCID 0000-0001-6959-3236
Filip Soeskov DavidovskiSection of Cardiovascular Medicine, Herlev-Gentofte Hospital, 2900 Hellerup, Denmark.ORCID 0000-0002-6642-416X
Tor Biering-SørensenSection of Cardiovascular Medicine, Herlev-Gentofte Hospital, 2900 Hellerup, Denmark.
Jørn CarlsenDepartment of Cardiology, Rigshospitalet, Copenhagen University Hospital, Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
Jens Ulrik Stæhr JensenSection of Respiratory Medicine, Herlev-Gentofte Hospital, 2900 Hellerup, Denmark.ORCID 0000-0003-4036-0521
Gentofte Hospital · DKHaukeland University Hospital · NOUniversity of Copenhagen · DKOdense University Hospital · DKTemple University · USThe University of Sydney · AUUniversity of Manchester · GB

Funding

Novo Nordisk Foundation NNF20OC0060657
6 · The paper itself

Abstract

Patients with chronic obstructive pulmonary disease (COPD) are prone to developing arterial hypertension, and many patients are treated with the calcium channel blocker amlodipine. However, it remains unclear whether using this drug potentially affects the risk of acute severe exacerbations (AECOPD) and all-cause mortality in these patients. The data were collected from Danish national registries, containing complete information on health, prescriptions, hospital admissions, and outpatient clinic visits. The COPD patients (

Indexed as

amlodipinebendroflumethiazidecalcium channel blockersCOPDexacerbationsthiazide

Identifiers

PMID37509614
PMCPMC10377707
OpenAlexW4384203607

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.